http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1435233-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_366b28c3ff8b5387bea525036766190d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 |
| filingDate | 2002-12-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4924ca5d73f18ebaa030691591bee884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be78a3426fe3909e7b875be2099dd298 |
| publicationDate | 2004-07-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1435233-A1 |
| titleOfInvention | Cyclosporin-based pharmaceutical compositions |
| abstract | A pharmaceutical formulation for the oralnadministration of cyclosporin is described, whichnformulation is capable of providing substantiallynconstant and foreseeable plasma levels of the activeningredient. The formulation has the following quali-quantitativencomposition by weight:n (a) cyclosporin in the amount of from about 8 to aboutn12% of the total weight; (b) ethanol in the amount of from about 12 to about 18%nof the total weight; (c) a polyoxyethylene/polyoxypropylene block copolymernin the amount of from about 8 to about 12% of the totalnweight; (d) water in the amount of from about 4 to about 6% ofnthe total weight; (e) a solubilizer having an HLB from 13 to 15 in thenamount of from about 28 to about 40% of the totalnweight; (f) an ester of a C 1 -C 6 alkyl alcohol and a C 14 -C 18 nsaturated fatty acid in the amount of from about 20 tonabout 30% of the total weight. |
| priorityDate | 2002-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.